Trivalent Chromium Treatment for Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Trivalent chromium has shown good results in abolishing inflammation and had a successful
result in treating animal model of rheumatoid arthritis. In addition to that, trivalent
chromium lacks many side effects which are related to the already known medications of the
disease.
So this study aims to evaluate the efficacy of trivalent chromium supplementation in
rheumatoid arthritis treatment and measuring the outcomes of that in rheumatoid arthritis
patients.